Skip to main content
Back To Top Top Back To Top
This website publishes administrative rules on their effective dates, as designated by the adopting state agencies, colleges, and universities.

Rule 3701-67-06 | Child fatality review information system.

 

(A) The director shall provide a data collection tool for the review of child deaths or arrange for the use of a national child death review database. The individual data collection shall be maintained in a confidential manner.

(B) Each CFR board will use the director's data collection tool or the national child death review database to record the following information:

(1) Demographic information that includes:

(a) Age of the child;

(b) Sex of the child, identified as male or female;

(c) Race of the child, identified as black, white, native American, Asian, Alaskan native, native Hawaiian, Pacific islander, unknown or multiple;

(d) Ethnicity of the child identified as Hispanic or Latino origin; and

(e) Infant death information that includes:

(i) Gestational age;

(ii) Birth weight;

(iii) Multiple gestation;

(iv) Mother's number of pregnancies;

(v) Mother's number of live births;

(vi) Mother's number of living children;

(vii) Prenatal care provided during pregnancy of deceased infant;

(viii) Access or compliance issues related to prenatal care;

(ix) Medical conditions/complications during pregnancy;

(x) Medical complications in previous pregnancies;

(xi) Medication, drug or substance use during pregnancy;

(xii) Infant born drug exposed;

(xiii) Infant neonatal abstinence syndrome (NAS);

(xiv) Level of birth hospital;

(xv) At hospital discharge, was a case manager assigned;

(xvi) Whether mother attended postpartum visit;

(xvii) Did the infant stay in NICU more than one day;

(xviii) Did mother smoke in three months before pregnancy;

(xix) Did mother smoke at any time during pregnancy;

(xx) Was mother injured during pregnancy;

(xxi) Did mother have postpartum depression;

(xxii) Was infant ever breastfed;

(xxiii) Did infant have abnormal metabolic newborn screening results;

(xxiv) Prior to last seventy-two hours of life, did infant have history of medical conditions, symptoms, injury, vaccine administration, medications, feeding.

(2) Death related information, that includes:

(a) Year of child's death;

(b) Geographic location of death;

(c) Cause of death; and

(d) Contributing factors to death, that includes:

(i) Poisoning, overdose or acute intoxication, including:

(a) Type of substance involved;

(b) Storage location of substance;

(c) Product original container;

(d) Container child safety cap;

(e) Incident result of; and

(f) Poison control contacted.

(ii) Death related to sleeping environment, including:

(a) Was death related to sleeping/sleep environment;

(b) Incident sleep space;

(c) Position of child when put to sleep;

(d) Position of child when found;

(e) Usual sleep position;

(f) Availability of suitable sleep location;

(g) Usual sleep place;

(h) Child in new or different environment;

(i) Child placed to sleep with pacifier;

(j) Child wrapped or swaddled in blanket;

(k) Child overheated;

(l) Child exposed to second-hand smoke;

(m) Position of child's face when found;

(n) Position of child's neck when found;

(o) Status of child's airway;

(p) Objects in child's sleep environment and relation to airway obstruction;

(q) Caregiver/supervisor fell asleep when feeding child;

(r) Child sleeping in same room as caregiver/supervisor;

(s) Child sharing sleep surface with person(s) or animal(s);

(t) Reasons for sharing sleep surface; and

(u) Scene re-creation photo available.

(3) Data quality information that includes:

(a) Data entry completed for the case; and

(b) Preventability of the death.

(4) Any other information the CFR board considers relevant to the review.

(C) Individual data related to a child death review that is reported on the data collection tool or the national child death review database is not a public record under section 149.43 of the Revised Code.

Last updated February 16, 2023 at 8:29 AM

Supplemental Information

Authorized By: 3701.045
Amplifies: 3701.045, 307.626, 307.623
Five Year Review Date: 2/6/2028
Prior Effective Dates: 6/28/2001, 8/11/2011